Tender detail
Open-house medicine discount agreements for the active ingredient nintedanib
Summary
The procurement concerns non-exclusive discount agreements for medicines containing the active ingredient nintedanib, covering the period from 1 January 2027 to 31 December 2028. Under the open-house model, agreements may be concluded throughout this period. Medicines on the BfArM list of paediatric medicines under Section 35(5a) of the German Social Code, Book V, are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.